Table 3.
Multivariate linear regression analysis of the associations between serum 25(OH)D category (predictor variable) and fasting glucose, fasting insulin, HOMA-IR, HOMA-β and QUICKI (outcomes); adolescents aged 10–19 years, Korea National Health and Nutrition Examination Survey (KNHANES) 2009–2010
Model 1 | Model 2 | Model 3 | Model 4 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dependent variable | β | se | P value | β | se | P value | β | se | P value | β | se | P value |
Total participants (n 1466) | ||||||||||||
Fasting glucose | −0·473 | 0·245 | 0·054 | −0·462 | 0·245 | 0·061 | −0·484 | 0·246 | 0·050 | −0·463 | 0·245 | 0·060 |
Fasting insulin* | −0·064 | 0·014 | <0·001 | −0·063 | 0·014 | <0·001 | −0·067 | 0·014 | <0·001 | −0·063 | 0·013 | <0·001 |
HOMA-IR* | −0·069 | 0·015 | <0·001 | −0·068 | 0·014 | <0·001 | −0·072 | 0·014 | <0·001 | −0·068 | 0·014 | <0·001 |
QUICKI* | 0·010 | 0·002 | <0·001 | 0·010 | 0·002 | <0·001 | 0·010 | 0·002 | <0·001 | 0·010 | 0·002 | <0·001 |
HOMA-β* | −0·048 | 0·015 | 0·002 | −0·047 | 0·015 | 0·002 | −0·050 | 0·015 | 0·001 | −0·048 | 0·015 | 0·002 |
HOMA-β† | −0·006 | 0·012 | 0·629 | −0·005 | 0·012 | 0·666 | −0·005 | 0·012 | 0·674 | −0·005 | 0·012 | 0·673 |
Lean participants (n 1158) | ||||||||||||
Fasting insulin* | −0·045 | 0·013 | <0·001 | −0·044 | 0·013 | 0·001 | −0·047 | 0·013 | 0·001 | −0·045 | 0·013 | 0·001 |
HOMA-IR* | −0·048 | 0·014 | 0·001 | −0·047 | 0·014 | 0·001 | −0·049 | 0·014 | 0·001 | −0·048 | 0·014 | 0·001 |
QUICKI* | 0·007 | 0·002 | 0·001 | 0·007 | 0·002 | 0·001 | 0·007 | 0·002 | 0·001 | 0·007 | 0·002 | 0·001 |
Overweight or obese participants (n 308) | ||||||||||||
Fasting insulin* | −0·149 | 0·038 | <0·001 | −0·155 | 0·036 | <0·001 | −0·159 | 0·036 | <0·001 | −0·154 | 0·037 | <0·001 |
HOMA-IR* | −0·163 | 0·040 | <0·001 | −0·170 | 0·038 | <0·001 | −0·174 | 0·037 | <0·001 | −0·168 | 0·038 | <0·001 |
QUICKI* | 0·022 | 0·005 | <0·001 | 0·023 | 0·005 | <0·001 | 0·024 | 0·005 | <0·001 | 0·023 | 0·005 | <0·001 |
25(OH)D, 25-hydroxyvitamin D; HOMA-IR, homeostatic model assessment–insulin resistance index; HOMA-β, homeostatic model assessment–β-cell function; QUICKI, quantitative insulin-sensitivity check index.
Multivariate linear regression analyses were performed to assess the association between increasing 25(OH)D category (<37·5 nmol/l, 37·5 to <50 nmol/l, ≥50 nmol/l) and the change in fasting glucose, fasting insulin, HOMA-IR, HOMA-β and QUICKI, after adjustment for potential confounders. If there was an interaction between the three categories of serum 25(OH)D and BMI Z-scores (<85th percentile or ≥85th percentile), we split the group into two (lean v. overweight/obese). The modifying effect of overweight status on the relationship between the three categories of serum 25(OH)D and markers of insulin resistance was significant (test for interaction: P=0·046 for fasting insulin, P = 0·030 for HOMA-IR and P = 0·034 for QUICKI). No significant modifying effect of overweight status on the association between the 25(OH)D categories and fasting glucose or HOMA-β was observed. We entered potential confounders as follows: model 1 included age, sex, physical activity (PA) and BMI Z-score; model 2 included age, sex, PA and fat mass (g) Z-score; model 3 included age, sex, PA and fat mass (%) Z-score; and model 4 included age, sex, PA and fat mass index Z-score.
*The analysis was performed using natural log-transformed values for the dependent variables.
†The analysis was performed after additional adjustment of natural log-transformed HOMA-IR.